Related Experiment Videos
Low beta-adrenergic receptor concentration on human thymocytes
Clinical and Experimental Immunology
|January 1, 1983
Summary
Human thymocytes lack beta-adrenergic receptors, unlike mouse thymocytes and human T cells, affecting cyclic AMP response. This highlights species-specific receptor development in T cell ontogeny.
Area of Science:
- Immunology
- Cellular Biology
- Pharmacology
Background:
- Cyclic AMP (cAMP) levels in lymphoid cells can be modulated by agents like isoproterenol, PGE1, and adenosine.
- Understanding cAMP regulation is crucial for T cell function and development.
Purpose of the Study:
- To investigate the differential effects of cAMP-elevating agents on human and mouse thymocytes, and human peripheral T lymphocytes.
- To determine the correlation between beta-adrenergic receptor density and isoproterenol-induced cAMP increase in these cell types.
Main Methods:
- Treatment of mouse thymocytes, human thymocytes, and human peripheral T lymphocytes with isoproterenol, PGE1, and adenosine.
- Measurement of intracellular cyclic AMP levels.
- Quantification of beta-adrenergic receptor density using 3H-dihydroalprenolol binding assays.
Main Results:
- Human thymocytes showed insensitivity to isoproterenol but responded to PGE1 and adenosine.
- Mouse thymocytes and human peripheral T lymphocytes responded to isoproterenol, PGE1, and adenosine.
- A low density of beta-adrenergic receptors was found on human thymocytes, contrasting with higher densities on mouse thymocytes and human T lymphocytes.
Conclusions:
- The ontogeny of beta-adrenergic receptors differs significantly between mice and humans.
- Human thymocytes exhibit a distinct developmental pathway regarding beta-adrenergic receptor expression compared to mouse thymocytes.
- Caution is advised when extrapolating findings from animal models to human T cell development.